Henry O. Gosebruch

Leeftijd : 49

Vermogen : 20 192 318 USD

Belangrijkste bedrijven :

Neumora Therapeutics, Inc. -

Acelyrin, Inc.

Overzicht

Currently, Henry O. Gosebruch holds the position of President, Chief Executive Officer & Director at Neumora Therapeutics, Inc.

He is also on the board of ACELYRIN, Inc.

In the past he held the position of Chief Strategy Officer & Executive Vice President at AbbVie, Inc. and Co-Head-Mergers & Acquisitions North America at JPMorgan Securities LLC.

He received an undergraduate degree from The Wharton School of the University of Pennsylvania.

Posities en verantwoordelijkheden van Henry O. Gosebruch

Naam	Titel	Van
Neumora Therapeutics, Inc. (Biotechnologie & Medisch Onderzoek)	President, Chief Executive Officer & Director	2023
Acelyrin, Inc. (Biotechnologie & Medisch Onderzoek)	Director	2023

Belangnemingen van Henry O. Gosebruch

Naam	Aandelen	%	Totale waarde
AbbVie Inc. (ABBV) (Farmaceutische producten)	98 761	0,0056%	13 943 078 USD
Neumora Therapeutics, Inc. (NMRA) (Biotechnologie & Medisch Onderzoek)	524 793	0,34%	5 730 740 USD
Acelyrin, Inc. (SLRN) (Biotechnologie & Medisch Onderzoek)	50 000	0,051%	509 250 USD
Aptinyx Inc. (APTX) (Farmaceutische producten)	125 000	0,18%	9 250 USD

Henry O. GosebruchPersoonlijk netwerk

Naam	Verwante bedrijven
Alaa Halawa	Neumora Therapeutics, Inc.
Matthew K. Fust	Neumora Therapeutics, Inc.
Nicholas Brandon	Neumora Therapeutics, Inc.
Michael Gold	Neumora Therapeutics, Inc.
Joshua Pinto	Neumora Therapeutics, Inc.
Daljit Singh Aurora	Neumora Therapeutics, Inc.
Robert Lenz	Neumora Therapeutics, Inc.
Kári Stefánsson	Neumora Therapeutics, Inc.
Kristina M. Burow	Neumora Therapeutics, Inc.
Carol Suh	Neumora Therapeutics, Inc.